This policy brief explores the dangerous potential of neuroweapons, the need for a “Neuroshield” to protect democracies from the risks of disinformation, the implications of brain-computer interfaces and other national security considerations related to brain health.
Harris A. Eyre, William Hynes, Geoffrey F. L. Ling, Jo-An Occhipinti, Rym Ayadi, Michael D. Matthews, Ryan Abbott, Patrick LoveAugust 10, 2023
Economic security has become a top priority for the West following the disruptions caused by COVID-19, the Russia-Ukraine war and the growing threat of China. Could investing in brain capital help build more resilient economies?
William Hynes, Paweł Świeboda, Patrick Love, Jo-An Occhipinti, Harris A. EyreAugust 2, 2023
Precision psychiatry promises to more accurately diagnose and treat patients. Brain health experts call for European researchers, policymakers and industry to work together to advance the field and give Europe a competitive edge.
Marion Leboyer, Paweł Świeboda, Harris A. Eyre, Veronique Briquet-LaugierJune 5, 2023
Brain diseases have profound impacts on our health, our communities and the economy. In this brief, fellow Harris A. Eyre explains why Texas needs to establish a state research institute to tackle a growing brain health crisis.
The authors assert that the time is ripe for the United States and Europe to take the lead on shepherding a systems-level change in the recycling market, strengthened by government regulation and legislation. They examine the economic, social, and environmental impacts of mismanaged waste and argue that the Covid-19 pandemic could serve as a catalyst for action toward a global, circular economy.
The human papillomavirus (HPV) affects over 80 million Americans, causing more than 40,000 cases of HPV-associated cancers in the U.S. In 2006, the FDA licensed the first HPV vaccine, which could help save thousands of lives; no cure for HPV currently exists. However, the political controversy raised by the vaccine has limited its acceptance and use. Such resistance potentially jeopardizes an opportunity to reduce cancer rates in Texas and the broader United States.
Kirstin R.W. Matthews, Monica M. MatsumotoOctober 6, 2014